Letter to the editor: 'Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline'

被引:0
|
作者
Jafari, Hedayat [1 ]
Shafipour, Vida [1 ]
Kamali, Mahsa [2 ]
Mollaei, Amirabbas [3 ]
机构
[1] Mazandaran Univ Med Sci, Addict Inst, Tradit & Complementary Med Res Ctr, Sari, Iran
[2] Mazandaran Univ Med Sci, Cardiovasc Res Ctr, Sari, Iran
[3] Guilan Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Rasht, Iran
关键词
D O I
10.1093/eurjcn/zvad057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E133 / E134
页数:2
相关论文
共 50 条
  • [31] AMIODARONE-INDUCED THYROTOXICOSIS - CLINICAL PRESENTATION AND EXPANDED INDICATIONS FOR THYROIDECTOMY
    MULLIGAN, DC
    MCHENRY, CR
    KINNEY, W
    ESSELSTYN, CB
    NUMANN, PJ
    ROHER, H
    ALBERTSON, D
    SURGERY, 1993, 114 (06) : 1114 - 1119
  • [32] Diagnosis and Clinical Course of Three Adolescents with Amiodarone-Induced Hyperthyroidism
    Julia Gesing
    Julia Hoppmann
    Roman Gebauer
    Roland Pfäffle
    Astrid Bertsche
    Wieland Kiess
    Pediatric Cardiology, 2018, 39 : 1707 - 1716
  • [33] Letter to the Editor on "Adherence to the AAOS Clinical Practice Guidelines for Nonoperative Management of Knee Osteoarthritis"
    Spitzer, Andrew I.
    Bert, Jack M.
    JOURNAL OF ARTHROPLASTY, 2020, 35 (09) : 2691 - 2692
  • [34] Reducing the Incidence of Amiodarone-related Phlebitis Through Utilization of Evidence-based Practice
    Murphy, Kristie
    Murphy, Jane
    Fischer-Cartlidge, Erica
    WORLDVIEWS ON EVIDENCE-BASED NURSING, 2020, 17 (05) : 385 - 392
  • [35] Incidence, Clinical Course, and Risk Factors of Amiodarone-Induced Thyroid Dysfunction in Japanese Adults With Congenital Heart Disease
    Takeuchi, Daiji
    Honda, Kei
    Shinohara, Tokuko
    Inai, Kei
    Toyohara, Keiko
    Nakanishi, Toshio
    CIRCULATION JOURNAL, 2015, 79 (08) : 1828 - 1834
  • [36] Letter to the Editor: "Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline"
    Davis, Susan R.
    Stuckey, Bronwyn G. A.
    Magraith, Karen S.
    Baber, Rodney J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (04) : E1917 - E1918
  • [37] Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline"
    Sugiyama, Toshihiro
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (11) : 5178 - 5179
  • [38] Letter to the Editor: Comment on Pagets Disease Clinical Practice Guideline by Singer et al Response
    Singer, Frederick R.
    Bone, Henry G., III
    Hoskings, David J.
    Lyles, Kenneth W.
    Reid, Ian R.
    Siris, Ethel S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (05)
  • [39] Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline"
    Anagnostis, Panagiotis
    Kenanidis, Eustathios
    Potoupnis, Michael
    Tsiridis, Eleftherios
    Goulisl, Dimitrios G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (01) : 378 - 379
  • [40] Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline"
    Rodriguez, Elena Gonzalez
    Lamy, Olivier
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08) : 3535 - 3536